SCHEMBL68236

SCHEMBL68236

CC(C)(C)CN(Cc1cc(Br)cs1)C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
ALDH1A1 P00352 3/20 0.33
LMNA P02545 3/20 0.33
DAO P14920 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
GSK3B P49841 1/20 0.33
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HCAR3 P49019 1/20 0.31
HCAR2 Q8TDS4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8154608 0.76 MEN1 (0.42) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL1400848 0.75 LMNA (0.42) HSP90AA1HSP90AB1CYP2C9CYP2C19PDK1
SCHEMBL3652855 0.73 POLB (0.35) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL2177178 0.73 PTGES (0.58) ALDH1A1LMNAMEN1KMT2AL3MBTL1
SCHEMBL1156558 0.70 PKM (0.38) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL3654647 0.69 CNR2 (0.35) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL4404774 0.69 AAK1 (0.36) HSP90AA1HSP90AB1CYP2C9CYP2C19PDK1
SCHEMBL4720974 0.69 TSHR (0.33) CYP2C19ALDH1A1
SCHEMBL13028665 0.68 CES2 (0.39) HSP90AA1HSP90AB1CYP2C9CYP2C19PDK1
SCHEMBL2600063 0.68 SLC6A4 (0.35) CES2CES1ALDH1A1LMNASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022079-B2 Methods of modulating PPAR gamma-type receptors GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-09-20 US disclosed
EP-1638964-B1 NOVEL COMPOUNDS THAT MODULATE PPAR-GAMMA TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RES & DEV (FR) 2011-07-27 EP disclosed
EP-1814871-B1 COMPOUNDS THAT MODULATE PPARY TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RES & DEV (FR) 2011-03-02 EP disclosed
EP-2190822-A2 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-06-02 EP disclosed
WO-2009041705-A9 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS TAKEDA PHARMACEUTICAL (JP) 2009-08-13 WO disclosed
WO-2009041705-A2 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-04-02 WO disclosed